256 related articles for article (PubMed ID: 28600667)
41. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
Furuya S; Kono H; Hara M; Hirayama K; Sun C; Fujii H
J Surg Res; 2015 Dec; 199(2):487-93. PubMed ID: 26141869
[TBL] [Abstract][Full Text] [Related]
42. Preventive effects of interleukin-6 in lipopolysaccharide/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages.
Li L; Duan C; Zhao Y; Zhang X; Yin H; Wang T; Huang C; Liu S; Yang S; Li X
Int Immunopharmacol; 2017 Oct; 51():99-106. PubMed ID: 28822324
[TBL] [Abstract][Full Text] [Related]
43. AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy.
Liu YM; Lv J; Zeng QL; Shen S; Xing JY; Zhang YY; Zhang ZH; Yu ZJ
Exp Cell Res; 2017 Sep; 358(2):335-342. PubMed ID: 28689811
[TBL] [Abstract][Full Text] [Related]
44. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
[TBL] [Abstract][Full Text] [Related]
45. Betulinic acid prevention of d-galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms.
Zheng ZW; Song SZ; Wu YL; Lian LH; Wan Y; Nan JX
J Pharm Pharmacol; 2011 Apr; 63(4):572-8. PubMed ID: 21401610
[TBL] [Abstract][Full Text] [Related]
46. PER1 prevents excessive innate immune response during endotoxin-induced liver injury through regulation of macrophage recruitment in mice.
Wang T; Wang Z; Yang P; Xia L; Zhou M; Wang S; Du J; Zhang J
Cell Death Dis; 2016 Apr; 7(4):e2176. PubMed ID: 27054331
[TBL] [Abstract][Full Text] [Related]
47. The Key Molecular Mechanisms of Sini Decoction Plus Ginseng Soup to Rescue Acute Liver Failure: Regulating PPARα to Reduce Hepatocyte Necroptosis?
He Y; Zhang Y; Zhang J; Hu X
J Inflamm Res; 2022; 15():4763-4784. PubMed ID: 36032938
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of O-glycosylation aggravates GalN/LPS-induced liver injury through activation of ER stress.
Xu D; Zhao Z; Li Y; Shang C; Liu L; Yan J; Zheng Y; Wen Z; Gu T
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):741-748. PubMed ID: 34549685
[TBL] [Abstract][Full Text] [Related]
49. Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency.
Pawlak M; Baugé E; Lalloyer F; Lefebvre P; Staels B
Mol Endocrinol; 2015 Aug; 29(8):1134-43. PubMed ID: 26087172
[TBL] [Abstract][Full Text] [Related]
50. Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
Wu YL; Lian LH; Wan Y; Nan JX
Chem Biol Interact; 2010 Dec; 188(3):526-34. PubMed ID: 20850421
[TBL] [Abstract][Full Text] [Related]
51. Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
Akashi I; Kagami K; Hirano T; Oka K
J Pharm Pharmacol; 2009 Apr; 61(4):473-8. PubMed ID: 19298694
[TBL] [Abstract][Full Text] [Related]
52. Hepatic Macrophages are the Cell Source of Hepatic Procalcitonin in Acute Liver Failure.
Zheng W; Ye B; Liang X; Shui L; Lou G; Liu Y; Zheng M
Cell Physiol Biochem; 2018; 47(3):1133-1140. PubMed ID: 29913443
[TBL] [Abstract][Full Text] [Related]
53. Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.
Shirozu K; Hirai S; Tanaka T; Hisaka S; Kaneki M; Ichinose F
Shock; 2014 Dec; 42(6):570-577. PubMed ID: 25046541
[TBL] [Abstract][Full Text] [Related]
54. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice.
Masaki T; Chiba S; Tatsukawa H; Yasuda T; Noguchi H; Seike M; Yoshimatsu H
Hepatology; 2004 Jul; 40(1):177-84. PubMed ID: 15239101
[TBL] [Abstract][Full Text] [Related]
55. Geraniol ameliorates acute liver failure induced by lipopolysaccharide/D-galactosamine via regulating macrophage polarization and NLRP3 inflammasome activation by PPAR-γ methylation Geraniol alleviates acute liver failure.
Ma J; Xu Y; Zhang M; Li Y
Biochem Pharmacol; 2023 Apr; 210():115467. PubMed ID: 36849063
[TBL] [Abstract][Full Text] [Related]
56. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
Huang H; Zhang X; Li J
J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
[TBL] [Abstract][Full Text] [Related]
57. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
[TBL] [Abstract][Full Text] [Related]
58. Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation.
Li X; Gou C; Yang H; Qiu J; Gu T; Wen T
Scand J Gastroenterol; 2014 Aug; 49(8):993-1000. PubMed ID: 24797709
[TBL] [Abstract][Full Text] [Related]
59. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
Yin X; Gong X; Jiang R; Zhang L; Wang B; Xu G; Wang C; Wan J
J Gastroenterol Hepatol; 2014 Jun; 29(6):1308-15. PubMed ID: 24476051
[TBL] [Abstract][Full Text] [Related]
60. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW
J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
